Dr. Rogers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 South St
Waltham, MA 02453Phone+1 857-241-2276
Summary
- Dr. Adam Rogers is an ophthalmologist in Waltham, MA and is affiliated with multiple hospitals in the area, including Tufts Medical Center and St. Elizabeth's Medical Center. He received his medical degree from Emory University School of Medicine and has been in practice 21 years. He specializes in retinal disease and is experienced in retina surgery and vitreoretinal disease.
Education & Training
- Tufts Medical CenterFellowship, Surgical Retina and Vitreous, 2000 - 2001
- Boston University Medical CenterResidency, Ophthalmology, 1997 - 2000
- Beth Israel Deaconess Medical CenterInternship, Surgery, 1996 - 1997
- Emory University School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 2000 - 2026
- ME State Medical License Active through 2003
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Eplerenone for Central Serous Chorioretinopathy Start of enrollment: 2013 May 01
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-Related Macular Degeneration.Jeffrey S Heier, Michael N Cohen, Daniel L Chao, Anthony Pepio, Yoko Shiraga
Ophthalmology. 2024-12-01 - 5 citationsShort-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective studyHamid-Reza Moein, Lauren W. Bierman, Eduardo A. Novais, Carlos Moreira-Neto, Caroline R. Baumal
International Journal of Retina and Vitreous. 2019-09-09 - 31 citationsExpanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessationDavid R. Lally, Jeffrey S. Heier, Caroline R. Baumal, Andre J. Witkin, Steven Maler
International Journal of Retina and Vitreous. 2016-07-18
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: